Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Zhaohua Cai"

  • Modify Search
  • Create Alert
  • Save Search

19 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/02/2017
e.g., 08/02/2017
Format Results
  • You have accessRestricted access
    PTEN Activity Is Modulated During Ischemia and ReperfusionInvolvement in the Induction and Decay of Preconditioning
    Zheqing Cai and Gregg L. Semenza
    Circulation Research. 2005;97:1351-1359, originally published December 8, 2005
    https://doi.org/10.1161/01.RES.0000195656.52760.30
    Download PDF
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 1. Analysis of cardiac protection and signal transduction induced by IPC. A, LVDP was measured in Langendorff-perfused rat hearts under the fol...Show More
    Figure 1. Analysis of cardiac protection and signal transduction induced by IPC. A, LVDP was measured in Langendorff-perfused rat hearts under the following conditions: nonischemic hearts (NIS); hearts subjected to I-30/R-45 (I/R); hearts subjected to I-15/R-30 before I/R (IPC); and hearts in which 1 μmol/L wortmannin (WT) was perfused (red bar) during the last 15 minutes of IPC (IPC+WT). *P<0.01 compared with I/R or IPC+WT (n=5). B, Lysates were prepared from nonischemic hearts and hearts that were subjected to I-15/R-30 as an IPC stimulus in the presence or absence of WT. Heart lysates were analyzed for p-Akt, total Akt, p-p70, and β-actin by immunoblot assays. C and D, The levels of p-Akt and p-p70 were quantified by densitometric analysis of immunoblots.Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 2. Effect of ischemia-reperfusion on PTEN activity and protein levels. A, PTEN activity was determined, in the same heart lysates analyzed in F...Show More
    Figure 2. Effect of ischemia-reperfusion on PTEN activity and protein levels. A, PTEN activity was determined, in the same heart lysates analyzed in Figure 1B, by a specific PTEN phosphatase assay. B, PTEN protein levels were quantified by immunoblot assay in the same lysates. *P<0.01 compared with nonischemic hearts (NIS) or IPC plus wortmannin (IPC+WT) (n=3).Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 3. Effect of prolonged reperfusion on PTEN and Akt activities. A, PTEN phosphatase activity was determined in heart lysates prepared at baselin...Show More
    Figure 3. Effect of prolonged reperfusion on PTEN and Akt activities. A, PTEN phosphatase activity was determined in heart lysates prepared at baseline and after 15 minutes of ischemia followed by 30, 60, or 120 minutes of reperfusion. B, Lysates were subjected to immunoblot assays. C, Immunoblot data for PTEN and p-Akt were quantified by densitometry (n=3 to 4).Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 4. Effect of prolonged reperfusion on cardiac protection. A, LVDP was measured in hearts that were nonischemic (NIS); hearts subjected to I-30/...Show More
    Figure 4. Effect of prolonged reperfusion on cardiac protection. A, LVDP was measured in hearts that were nonischemic (NIS); hearts subjected to I-30/R-45 (I/R); subjected to I-15/R-30 before I/R (R-30); and subjected to I-15/R-120 before I/R (R-120) (n=4). B, Heart lysates were prepared and levels of cleaved caspase-3 (c-cas3) and intact PARP were determined by immunoblot assay. C and D, Relative levels of c-cas3 and PARP, respectively, were quantified by densitometric analysis of immunoblots. *P<0.05 compared with nonischemic hearts or R-30 hearts (n=3).Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 5. Effect of prolonged reperfusion on PTEN and Akt. Hearts were subjected to I-15. Vehicle only (CON) (A) or 1 μmol/L wortmannin (WT) (B) was a...Show More
    Figure 5. Effect of prolonged reperfusion on PTEN and Akt. Hearts were subjected to I-15. Vehicle only (CON) (A) or 1 μmol/L wortmannin (WT) (B) was added to perfusates after reperfusion for 15 minutes. After 30 (R-30) or 120 (R-120) minutes of reperfusion, heart lysates were analyzed for p-PTEN, total PTEN, p-Akt, and total Akt by immunoblot assay. C, Total PTEN levels were determined by densitometric analysis of immunoblots. *P<0.01 (n=3). D, Nonischemic heart lysates were subjected to immunoprecipitation (IP) with polyclonal rabbit anti-PTEN or isotype-matched control antibodies followed by immunoblot assay (IB) using an anti-Akt monoclonal antibody.Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 6. Ischemia-induced dephosphorylation and degradation of PTEN. A, Hearts were subjected to ischemia for the indicated time, and lysates were su...Show More
    Figure 6. Ischemia-induced dephosphorylation and degradation of PTEN. A, Hearts were subjected to ischemia for the indicated time, and lysates were subjected to immunoblot assay for PTEN (quantified in graph as band intensity) and β-actin. B, PTEN enzymatic activity was measured in lysates from nonischemic hearts (NIS) or hearts subjected to 30 minutes of ischemia (ISC). *P<0.01 compared with NIS (n=3). C, Immunoblot assay of phosphorylated and total PTEN levels in NIS and hearts subjected to 5 minutes of ischemia (ISC). *P<0.01 compared with NIS (n=3). D, Hearts were perfused with the indicated concentration of okadaic acid for 15 minutes followed by 15 minutes of ischemia. Lysates were subjected to immunoblot assays.Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 7. Proteasomal degradation of PTEN in the ischemic heart. A, Hearts were perfused with buffer containing the indicated concentration of MG132 f...Show More
    Figure 7. Proteasomal degradation of PTEN in the ischemic heart. A, Hearts were perfused with buffer containing the indicated concentration of MG132 for 15 minutes, followed by 15 minutes of ischemia, and lysates were subjected to immunoblot assays. B and C, Hearts were subjected to ischemia after perfusion with vehicle (ISC) or 1 μmol/L MG132 (ISC+MG) and the levels of total (B) and phosphorylated (C) PTEN were quantified by densitometry. *P<0.01 compared with nonischemic (NIS) or ISC+MG hearts (n=3 each). D, LVDP of NIS hearts and hearts subjected to 15 minutes of ischemia (ISC) (blue bar) and 30 minutes of reperfusion (REP) (red bar) after perfusion of MG132 (gray bar) at a concentration of 0, 2, or 4 μmol/L. *P<0.01 for MG4 or MG2 compared with MG0 (n=3 to 4).Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 8. Oxidation of PTEN by ischemia-reperfusion or H2O2. A, Lysates were prepared from hearts that were nonischemic (T-15) or exposed to 15 minute...Show More
    Figure 8. Oxidation of PTEN by ischemia-reperfusion or H2O2. A, Lysates were prepared from hearts that were nonischemic (T-15) or exposed to 15 minutes of ischemia followed by 0 to 30 minutes of reperfusion (T-30 to T-60). Aliquots were treated with iodoacetamide and analyzed by nonreducing (nonred) PAGE, followed by immunoblot assay to identify reduced (Re) and oxidized (Ox) forms of PTEN or were subjected to standard reducing (Red) PAGE followed by immunoblot assays as indicated. B, Ratio of oxidized:total PTEN and phosphorylated:total Akt at each time point was determined by densitometric analysis of immunoblots. C, Hearts were exposed to ischemia (0 to 20 minutes), followed by 5-minute reperfusion. Cell lysates were analyzed for PTEN, p-Akt, and Akt. D, Hearts were perfused with buffer containing 0 to 10 μmol/L H2O2 for 15 minutes. Hearts were homogenized in lysis buffer containing iodoacetamide. Aliquots were analyzed as described above. Dithiothreitol (DTT) was added to an aliquot of heart lysate to a final concentration of 10 mmol/L as a control for reduced PTEN. E, Akt was analyzed in hearts perfused with buffer alone or buffer containing 0.4 mmol/L 2-mercaptoethanol (2-ME) and subjected to I-15/R-5 or I-15/R-30.Show Less
  • You have access
    PTEN Activity Is Modulated During Ischemia and Reperfusion
    Zheqing Cai, Gregg L. Semenza
    Circulation Research December 2005, 97 (12) 1351-1359; DOI: https://doi.org/10.1161/01.RES.0000195656.52760.30
    By Zheqing Cai and Gregg L. Semenza
    Figure 1. Analysis of cardiac protection and signal transduction induced by IPC. A, LVDP was measured in Langendorff-perfused rat hearts under the fol...Show More
    Figure 1. Analysis of cardiac protection and signal transduction induced by IPC. A, LVDP was measured in Langendorff-perfused rat hearts under the following conditions: nonischemic hearts (NIS); hearts subjected to I-30/R-45 (I/R); hearts subjected to I-15/R-30 before I/R (IPC); and hearts in which 1 μmol/L wortmannin (WT) was perfused (red bar) during the last 15 minutes of IPC (IPC+WT). *P<0.01 compared with I/R or IPC+WT (n=5). B, Lysates were prepared from nonischemic hearts and hearts that were subjected to I-15/R-30 as an IPC stimulus in the presence or absence of WT. Heart lysates were analyzed for p-Akt, total Akt, p-p70, and β-actin by immunoblot assays. C and D, The levels of p-Akt and p-p70 were quantified by densitometric analysis of immunoblots.Show Less

Pages

  • 1
  • 2
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Ischemic biology - basic studies (Subject)

Journal

Source

  • Circulation Research 17
  • Circulation 2

Article Type

Article Type

  • Basic Science Reports 1
  • Brief Rapid Communications 1
  • Cell signalling/signal transduction 9
  • Integrative Physiology 17
  • Ischemic biology - basic studies 9

Content Type

Resource Type

  • Articles 3
  • Tables & Figures 16
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured